We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
Cap. Flow
-$2.79B
Cap. Flow %
-20.16%
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194

Top Buys

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$66.4M
2
VLO icon
Valero Energy
VLO
+$28.9M
3
SLB icon
SLB Ltd
SLB
+$24.8M
4
BNY
Bank of New York Mellon
BNY
+$22.6M
5
PEP icon
PepsiCo
PEP
+$20.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$182M
2
AAPL icon
Apple
AAPL
+$148M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.9M
4
AMGN icon
Amgen
AMGN
+$72.1M
5
TSLA icon
Tesla
TSLA
+$66.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.26%
2 Technology 28.78%
3 Financials 8.15%
4 Consumer Discretionary 7.54%
5 Industrials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSL icon
601
Carlisle Companies
CSL
$13.8B
$829K 0.01%
3,231
-595
-16% -$132K
WLY icon
602
John Wiley & Sons Class A
WLY
$2.59B
$797K 0.01%
23,407
-35,490
-60% -$1.29M
AXON
603
Axon Enterprise
AXON
$42.4B
$778K 0.01%
3,988
-713
-15% -$148K
SUI icon
604
Sun Communities
SUI
$15B
$760K 0.01%
5,827
-6,979
-54% -$934K
ZM icon
605
Zoom
ZM
$26.7B
$760K 0.01%
11,194
-1,514
-12% -$101K
JBTM
606
JBT Marel
JBTM
$7.37B
$757K 0.01%
6,244
-937
-13% -$103K
RVTY icon
607
Revvity
RVTY
$12.1B
$754K 0.01%
6,349
-10,910
-63% -$1.34M
AIZ icon
608
Assurant
AIZ
$13.7B
$745K 0.01%
5,922
-5,332
-47% -$664K
PKG icon
609
Packaging Corp of America
PKG
$22.5B
$742K 0.01%
5,615
-5,206
-48% -$696K
LNN icon
610
Lindsay Corp
LNN
$1.17B
$737K 0.01%
6,177
+1,011
+20% +$126K
TECK icon
611
Teck Resources
TECK
$29.3B
$733K 0.01%
17,398
-1,489
-8% -$64K
PBA icon
612
Pembina Pipeline
PBA
$29B
$729K 0.01%
23,146
+1,375
+6% +$43.9K
BKI
613
DELISTED
Black Knight, Inc. Common Stock
BKI
$721K 0.01%
12,077
-8,789
-42% -$493K
CINF icon
614
Cincinnati Financial
CINF
$28.5B
$719K 0.01%
7,390
-8,411
-53% -$869K
RIVN icon
615
Rivian
RIVN
$23.9B
$718K 0.01%
43,125
+14,703
+52% +$205K
CM icon
616
Canadian Imperial Bank of Commerce
CM
$108B
$717K 0.01%
16,764
-51,035
-75% -$2.16M
MKTX icon
617
MarketAxess Holdings
MKTX
$4.19B
$714K 0.01%
2,730
-2,320
-46% -$692K
GS icon
618
Goldman Sachs
GS
$309B
$712K 0.01%
2,208
-219
-9% -$72K
GEN icon
619
Gen Digital
GEN
$16.1B
$704K 0.01%
37,953
-38,687
-50% -$677K
WPM icon
620
Wheaton Precious Metals
WPM
$50.9B
$703K 0.01%
16,247
TRP icon
621
TC Energy
TRP
$71.2B
$701K 0.01%
17,325
WPC icon
622
W.P. Carey
WPC
$17B
$700K 0.01%
10,581
-15,027
-59% -$1.04M
SCHL icon
623
Scholastic
SCHL
$752M
$689K 0.01%
17,714
BLDP
624
Ballard Power Systems
BLDP
$865M
$685K ﹤0.01%
156,212
-961,512
-86% -$4.38M
WYNN icon
625
Wynn Resorts
WYNN
$10.3B
$680K ﹤0.01%
6,442
-1,073
-14% -$115K

Similar funds

Candriam SCA's Q2 2023 Portfolio in Review

As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.

  • Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
  • Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
  • Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
  • Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
  • Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
  • Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
  • Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.